Covestro AG

Informe acción XTRA:1COV

Capitalización de mercado: €10.8b

Covestro Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Los beneficios de Covestro han disminuido a una tasa media anual de -35%, mientras que en la industria Chemicals los beneficios crecieron en un 9.6% anualmente. Los ingresos han ido creciendo a una tasa media de 6.2% al año.

Información clave

-35.0%

Tasa de crecimiento de los beneficios

-35.5%

Tasa de crecimiento del BPA

Crecimiento de la industria Chemicals 12.4%
Tasa de crecimiento de los ingresos6.2%
Rentabilidad financiera-4.0%
Margen neto-1.8%
Próxima actualización de resultados26 Feb 2025

Actualizaciones de resultados anteriores recientes

Recent updates

Covestro AG's (ETR:1COV) Intrinsic Value Is Potentially 96% Above Its Share Price

Jun 17
Covestro AG's (ETR:1COV) Intrinsic Value Is Potentially 96% Above Its Share Price

Covestro AG Just Missed Earnings; Here's What Analysts Are Forecasting Now

May 06
Covestro AG Just Missed Earnings; Here's What Analysts Are Forecasting Now

Covestro (ETR:1COV) Takes On Some Risk With Its Use Of Debt

Mar 20
Covestro (ETR:1COV) Takes On Some Risk With Its Use Of Debt

Is Covestro AG (ETR:1COV) Trading At A 38% Discount?

Feb 01
Is Covestro AG (ETR:1COV) Trading At A 38% Discount?

Does Covestro (ETR:1COV) Have A Healthy Balance Sheet?

Dec 01
Does Covestro (ETR:1COV) Have A Healthy Balance Sheet?

Should You Investigate Covestro AG (ETR:1COV) At €47.18?

Nov 13
Should You Investigate Covestro AG (ETR:1COV) At €47.18?

Are Investors Undervaluing Covestro AG (ETR:1COV) By 50%?

Oct 08
Are Investors Undervaluing Covestro AG (ETR:1COV) By 50%?

Is Covestro (ETR:1COV) Using Too Much Debt?

Aug 21
Is Covestro (ETR:1COV) Using Too Much Debt?

Is It Time To Consider Buying Covestro AG (ETR:1COV)?

Jul 31
Is It Time To Consider Buying Covestro AG (ETR:1COV)?

An Intrinsic Calculation For Covestro AG (ETR:1COV) Suggests It's 27% Undervalued

Jun 25
An Intrinsic Calculation For Covestro AG (ETR:1COV) Suggests It's 27% Undervalued

Does Covestro (ETR:1COV) Have A Healthy Balance Sheet?

May 02
Does Covestro (ETR:1COV) Have A Healthy Balance Sheet?

Are Investors Undervaluing Covestro AG (ETR:1COV) By 50%?

Feb 04
Are Investors Undervaluing Covestro AG (ETR:1COV) By 50%?

Is Covestro (ETR:1COV) A Risky Investment?

Jan 19
Is Covestro (ETR:1COV) A Risky Investment?

Is Now An Opportune Moment To Examine Covestro AG (ETR:1COV)?

Dec 12
Is Now An Opportune Moment To Examine Covestro AG (ETR:1COV)?

Estimating The Intrinsic Value Of Covestro AG (ETR:1COV)

Oct 23
Estimating The Intrinsic Value Of Covestro AG (ETR:1COV)

Is Covestro (ETR:1COV) Using Too Much Debt?

Sep 14
Is Covestro (ETR:1COV) Using Too Much Debt?

Is Now An Opportune Moment To Examine Covestro AG (ETR:1COV)?

Aug 18
Is Now An Opportune Moment To Examine Covestro AG (ETR:1COV)?

Is Covestro (ETR:1COV) Using Too Much Debt?

Jun 16
Is Covestro (ETR:1COV) Using Too Much Debt?

Is Now The Time To Look At Buying Covestro AG (ETR:1COV)?

May 11
Is Now The Time To Look At Buying Covestro AG (ETR:1COV)?

Covestro (ETR:1COV) Will Pay A Larger Dividend Than Last Year At €3.40

Apr 20
Covestro (ETR:1COV) Will Pay A Larger Dividend Than Last Year At €3.40

Covestro's (ETR:1COV) Dividend Will Be Increased To €3.40

Apr 06
Covestro's (ETR:1COV) Dividend Will Be Increased To €3.40

Is Now The Time To Look At Buying Covestro AG (ETR:1COV)?

Feb 09
Is Now The Time To Look At Buying Covestro AG (ETR:1COV)?

Covestro (ETR:1COV) Seems To Use Debt Rather Sparingly

Dec 29
Covestro (ETR:1COV) Seems To Use Debt Rather Sparingly

When Should You Buy Covestro AG (ETR:1COV)?

Oct 27
When Should You Buy Covestro AG (ETR:1COV)?

Is It Time To Consider Buying Covestro AG (ETR:1COV)?

Jul 08
Is It Time To Consider Buying Covestro AG (ETR:1COV)?

Is Covestro (ETR:1COV) A Risky Investment?

Jun 23
Is Covestro (ETR:1COV) A Risky Investment?

An Intrinsic Calculation For Covestro AG (ETR:1COV) Suggests It's 32% Undervalued

May 10
An Intrinsic Calculation For Covestro AG (ETR:1COV) Suggests It's 32% Undervalued

We Think Shareholders May Want To Consider A Review Of Covestro AG's (ETR:1COV) CEO Compensation Package

Apr 09
We Think Shareholders May Want To Consider A Review Of Covestro AG's (ETR:1COV) CEO Compensation Package

Is Now An Opportune Moment To Examine Covestro AG (ETR:1COV)?

Mar 28
Is Now An Opportune Moment To Examine Covestro AG (ETR:1COV)?

Here's Why Covestro (ETR:1COV) Can Manage Its Debt Responsibly

Mar 14
Here's Why Covestro (ETR:1COV) Can Manage Its Debt Responsibly

What Type Of Shareholders Make Up Covestro AG's (ETR:1COV) Share Registry?

Mar 01
What Type Of Shareholders Make Up Covestro AG's (ETR:1COV) Share Registry?

Is Covestro AG (ETR:1COV) A Strong Dividend Stock?

Feb 16
Is Covestro AG (ETR:1COV) A Strong Dividend Stock?

Is Covestro AG (ETR:1COV) Trading At A 50% Discount?

Feb 03
Is Covestro AG (ETR:1COV) Trading At A 50% Discount?

Did You Participate In Any Of Covestro's (ETR:1COV) Fantastic 125% Return ?

Jan 20
Did You Participate In Any Of Covestro's (ETR:1COV) Fantastic 125% Return ?

Covestro AG's (ETR:1COV) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Jan 05
Covestro AG's (ETR:1COV) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

How Is Covestro's (ETR:1COV) CEO Compensated?

Dec 21
How Is Covestro's (ETR:1COV) CEO Compensated?

Is It Too Late To Consider Buying Covestro AG (ETR:1COV)?

Dec 08
Is It Too Late To Consider Buying Covestro AG (ETR:1COV)?

Is Covestro AG (ETR:1COV) Popular Amongst Institutions?

Nov 25
Is Covestro AG (ETR:1COV) Popular Amongst Institutions?

Desglose de ingresos y gastos

Cómo gana y gasta dinero Covestro. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).


Historial de beneficios e ingresos

XTRA:1COV Ingresos, gastos y beneficios (EUR Millions)
FechaIngresosBeneficiosGastos G+AGastos de I+D
30 Sep 2414,149-2611,846364
30 Jun 2414,114-3251,851365
31 Mar 2414,144-2071,854360
31 Dec 2314,377-1981,865374
30 Sep 2314,995-9101,900372
30 Jun 2316,045-8671,932369
31 Mar 2317,028-7141,960372
31 Dec 2217,968-2721,975361
30 Sep 2218,3429291,977359
30 Jun 2218,0261,3891,974371
31 Mar 2217,2791,6391,931362
31 Dec 2115,9031,6161,861341
30 Sep 2114,5721,6261,759330
30 Jun 2113,0301,3331,653298
31 Mar 2111,2308321,527270
31 Dec 2010,7064591,529262
30 Sep 2010,5631841,593253
30 Jun 2010,9651521,649254
31 Mar 2012,0203931,756263
31 Dec 1912,4125521,783266
30 Sep 1912,8205941,809275
30 Jun 1913,3609431,852276
31 Mar 1914,0121,3581,905276
31 Dec 1814,6161,8231,924276
30 Sep 1814,8662,3101,922275
30 Jun 1814,6962,3051,897278
31 Mar 1814,3312,1851,859278
31 Dec 1714,1382,0091,859274
30 Sep 1713,6331,5671,874267
30 Jun 1713,1231,3351,860266
31 Mar 1712,6151,0811,846260
31 Dec 1611,9047951,815259
30 Sep 1611,6855871,755261
30 Jun 1611,6834881,708257
31 Mar 1611,9034101,691258
31 Dec 1512,0823431,640256
30 Sep 1512,2644221,593243
30 Jun 1512,3063611,568228
31 Mar 1511,9562981,483220
31 Dec 1411,7612721,448214
31 Dec 1311,3571801,441222

Ingresos de calidad: 1COV actualmente no es rentable.

Margen de beneficios creciente: 1COV actualmente no es rentable.


Análisis del flujo de caja libre vs. Beneficios


Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: 1COV no es rentable, y las pérdidas han aumentado en los últimos 5 años a un ritmo de 35% al año.

Acelerando crecimiento: No se puede comparar el crecimiento de los beneficios de 1COV en el último año con su promedio de 5 años, ya que actualmente no es rentable.

Beneficios vs. Industria: 1COV no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Chemicals (5%).


Rentabilidad financiera

Alta ROE: 1COV tiene una rentabilidad financiera negativa (-4.03%), ya que actualmente no es rentable.


Rentabilidad económica


Rendimiento del capital invertido


Descubre empresas con buenos resultados en el pasado